Aeon Global Health Corp.
Healthcare · Services-Medical Laboratories · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | |
|---|---|---|---|---|---|---|
| Revenue | $12.9M | $16.3M | $20.2M | $34.6M | $769,000 | $1.2M |
| Operating income | −$3.0M | −$780,536 | −$5.4M | $5.8M | −$8.7M | −$7.1M |
| Net income | −$252,665 | −$8.0M | −$32.1M | $5.3M | −$2.4M | −$1.6M |
| Total assets | $3.9M | $11.0M | $16.7M | $51.7M | $4.2M | $8.2M |
| Total liabilities | $9.9M | $10.5M | $8.7M | $11.7M | $4.6M | $3.0M |
| Equity | $1.2M | $488,554 | $8.0M | $39.9M | −$465,000 | $5.2M |
| EPS (diluted) | $-1.01 | $-1.15 | $-4.51 | $1.32 | $9.64 | — |
| Shares out. | 9.9M | 7.4M | 7.2M | 5.8M | 42.2M | 41.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2019- Operating margin
- −22.8%
- Net margin
- −2.0%
- Return on equity
- −20.8%
- Return on assets
- −6.5%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 252.9%
- Debt / equity
- 8.15×
- Book value / share
- $0.12
- Revenue growth (YoY)
- −20.7%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2019- Altman Z″ (distress)
- -58.64distress
- Accruals / assets
- −7.5%clean
- Beneish M-Score
- -4.13normal
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 14, 2019
- NT 10-Kmissed a reporting deadline ↗Sep 30, 2019
- NT 10-Qmissed a reporting deadline ↗May 16, 2019
- NT 10-Kmissed a reporting deadline ↗Sep 28, 2017
- NT 10-Qmissed a reporting deadline ↗May 16, 2017
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2016
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Ibex Investors Llc10% owner | Dec 10, 2020 | Sell | 74,173 | $0.07 |
| Ibex Investors Llc10% owner | Sep 2, 2020 | Sell | 42,934 | $0.07 |
| Ibex Investors Llc10% owner | Jul 9, 2020 | Sell | 18,276 | $0.07 |
| Ibex Investors Llc10% owner | Jun 18, 2020 | Sell | 9,889 | $0.07 |
| Roshan Hanif AOfficer — Chairman and CEO | Feb 28, 2019 | Grant | 911,501 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Other material eventNov 5, 2019
- Entered a material agreement · Unregistered equity saleOct 1, 2019
- Unregistered equity saleMar 5, 2019
- Prior financials not reliable (restatement)Jan 24, 2019
- Shareholder voteJan 23, 2019
- Other material eventDec 21, 2018
- Director / officer change · Shareholder voteDec 11, 2018
- Director / officer change · Other material eventOct 1, 2018
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- REVOKEDSep 30, 2022
- SC 13G/AJan 27, 2022
- SC 13G/AJan 15, 2021
- 4OWNERSHIP DOCUMENTDec 11, 2020
- 4Sep 3, 2020
- 4Jul 27, 2020
- 4Jun 22, 2020
- SC 13G/ASCHEDULE 13G/AJan 24, 2020
- 3PRIMARY DOCUMENTDec 20, 2019
- NT 10-QFORM NT 10-QNov 14, 2019
- 8-KFORM 8-KNov 5, 2019
- 10-KFORM 10-KOct 15, 2019
- 8-KFORM 8-KOct 1, 2019
- NT 10-KFORM NT 10-KSep 30, 2019
- 10-QJun 18, 2019
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.